Navigation Links
Extra payments to Medicare Advantage plans to total $8.5 billion in 2008
Date:9/4/2008

New York, NY, September 5, 2008Private Medicare Advantage (MA) plans will be paid an average 12.4 percent more per enrollee in 2008 compared to what the same enrollee would have cost in the traditional Medicare fee-for-service program, according to a new report from The Commonwealth Fund. Even if the payment reductions to MA plans mandated by the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) scheduled to take effect beginning in 2010 had been fully in place in 2008, MA plans still would have been paid 10.6 percent more than expected fee-for-service costs.

In the report, Brian Biles, professor of health policy at George Washington University, and colleagues estimate that extra payments to MA plans will amount to $986 over fee-for-service costs for each of about 8.7 million Medicare beneficiaries enrolled in Medicare Advantage plans, for a total of more than $8.5 billion in 2008 up from $3.9 billion in extra payments, or $795 per MA enrollee in 2004. Extra payments to MA plans between 2004 and 2008 will total nearly $33 billion.

The bulk of these extra payments were mandated by the Medicare Modernization Act of 2003, which was intended to expand the role of private plans in Medicare in an effort to reduce growth in Medicare spending. Since 2004, MA plan enrollment has increased from 4.8 million to the current 8.7 million.

"The legislation passed this year only partially addresses the overpayment problem in Medicare Advantage, and private plans still substantially raise the cost of serving Medicare beneficiaries," said Commonwealth Fund President Karen Davis. "Policymakers should carefully examine whether extra payments to Medicare Advantage plans are the best use of dollars for the beneficiaries the program is designed to serve."

The authors of the report, The Continuing Cost of Privatization: Extra Payments to Medicare Advantage Plans in 2008, note that eliminating extra payments to
'/>"/>

Contact: Mary Mahon
mm@cmwf.org
212-606-3853
Commonwealth Fund
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New study: Pine bark extract reduces ADHD symptoms in children
2. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
3. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
4. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
5. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
6. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
7. Portal vein thrombosis is common in extraportal vein obstruction
8. New study: pine bark extract boosts nitric oxide production
9. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
10. Broccoli sprout-derived extract protects against ultraviolet radiation
11. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... The ... the treatment of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, ... while also demonstrating its safety when used at home to combat hair loss. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy ... their partnership with Apex Physical Therapy (Apex) is official as of ... kind, compassionate, and empathetic care to local residents from their combined eight locations ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in ... from everyday life changes can lead to very serious, life-altering events. Fortunately nature ... with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses of ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th ... Calvary’s Camp Compass® has taken place at Kingsborough Community College in Brooklyn in each ... whom work for Calvary, and two junior counselors who were campers themselves just a ...
Breaking Medicine News(10 mins):Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3
... High Commission organized a seminar to explore the possibility ... ventures in services and manufacturing. They invited the // ... lead the discussion with Indian partners in Chennai on ... Hawkins and the group had discussion with healthcare providers ...
... to enable the smooth transfer of microorganisms and biological ... sign for Indian bioscience. But slow implementation of the ... to become the global hub of contract research and ... major player. , ,Discussions in mid-June between acting ...
... HIV during pregnancy because of their own or ... physiological changes during gestation. Irrespective of the mechanism ... HIV acquisition are significantly higher during pregnancy than ... HIV prevention, both to protect mothers from primary ...
... the Indraprastha Apollo Hospital in New Delhi expressed hope that ... successfully separated. // , ,The twins who are joined ... and doctors say that a major impediment to the surgery ... drainage vessel in the brain. Another possible roadblock is the ...
... his/her HIV status, but as far as law goes, you ... the fact that you have to rely on the quality ... ,The Wellington District Court, New Zealand, dismissed the charges of ... nuisance after not disclosing to his female partner his HIV ...
... by Sanofi Pasteur and Merck and found to be ... three doses over 6 months which has shown 100% successful. The ... vaccine protects against Human Papilloma virus infection and also genital warts, ... the market early next year and the profits would be great, ...
Cached Medicine News:Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:Women might be at increased risk of HIV during pregnancy 2Health News:Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical 2Health News:Gardasil vaccine for cervical cancer 2
(Date:9/1/2015)... OR YEHUDA, Israel , Sept. 1, ... HTWR ), a leading innovator of less invasive, miniaturized ... advanced heart failure, announced today that it has entered ... Ltd . ("Valtech").  Valtech is a privately held company ... transcatheter valve repair and replacement devices for the treatment ...
(Date:9/1/2015)... and BRUSSELS , Sept. 1, ... UCB (Euronext Brussels: UCB) today announced top-line results ... RomosozUmab Compared with Teriparatide in postmenopaUsal women with ... with bisphosphonatE therapy). The study (NCT01796301) met the ... favor of romosozumab in the percent change of ...
(Date:9/1/2015)... , Sept. 1, 2015  Dynatronics Corporation ... will present at the First Annual Ladenburg Thalmann ... York City.  Kelvyn H. Cullimore, Jr. , ... leading institutional investment representatives on Tuesday, September 29 ... Ladenburg Thalmann Conference will showcase leading-edge companies in ...
Breaking Medicine Technology:HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... Proteolix, Inc. today announced that data from preclinical ... the 2009 ACR/ARHP Annual Scientific Meeting on October 16 ... first in a new class of selective, irreversible proteasome ... clinical trials, including a Phase 2 study in patients ...
... N.J., Oct. 16 The Alabama Supreme Court today overturned ... entry of judgment in favor of NPC. NPC is pleased ... which demonstrates that the State of Alabama,s claims were unfounded. ... by NPC to reporting services resulted in overpayment to pharmacists ...
Cached Medicine Technology:Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting 2Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting 3Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court 2Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court 3
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... has developed a range of Milli-Q ... specific water quality requirements. Each of ... designed to specifically target contaminants detrimental ... molecular biology and ICP-MS. The systems ...
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Medicine Products: